US20180192888A1 - Blood Pressure and Cardiac Monitoring System and Method Thereof - Google Patents
Blood Pressure and Cardiac Monitoring System and Method Thereof Download PDFInfo
- Publication number
- US20180192888A1 US20180192888A1 US15/564,585 US201715564585A US2018192888A1 US 20180192888 A1 US20180192888 A1 US 20180192888A1 US 201715564585 A US201715564585 A US 201715564585A US 2018192888 A1 US2018192888 A1 US 2018192888A1
- Authority
- US
- United States
- Prior art keywords
- sensor
- target
- axis
- waveform
- blood pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0006—ECG or EEG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
- A61B5/02125—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
- A61B5/1107—Measuring contraction of parts of the body, e.g. organ or muscle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02416—Measuring pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
- A61B5/1102—Ballistocardiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/04—Measuring blood pressure
Definitions
- This disclosure is related to health monitoring devices, and more particularly, to a blood pressure and cardiac monitoring system and method for monitoring vital signs.
- the system comprises a sensing assembly and a processor communicatively coupled to the sensing assembly.
- the sensing assembly comprises a first accelerometer located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second accelerometer located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow.
- the processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
- a third sensor located either along the first or the second axis of the target generating a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle is provided.
- a fourth sensor located along any axis of the target is provided.
- the fourth sensor is configured to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.
- Embodiments of another disclosure relates to a sensing assembly for monitoring vital signs includes a first sensor located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow.
- a processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
- a housing is provided to encapsulate the processor and the sensing assembly.
- the processor is remotely located outside the sensing assembly and is communicatively coupled to the sensing assembly via a wireless network.
- FIG. 1 illustrates a block diagram of a blood pressure monitoring system according to an exemplary embodiment of a disclosure
- FIG. 2 illustrates a target with a blood pressure monitoring system of FIG. 1 placed on a sternum of the target according to a described embodiment of the disclosure
- FIG. 3 illustrates a sensing assembly for the blood pressure monitoring system of FIG. 1 according to a described embodiment of the disclosure
- FIG. 4 illustrates a graph of time-dependent waveforms according to an exemplary embodiment of the disclosure.
- ECG electrocardiography
- R-peak of the ECG signal can be used in the calculation of time intervals for monitoring blood pressure (e.g. RJ-time interval), R-peak or Q-peak of ECG signal for monitoring cardiac activity (e.g. pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.) or as the trigger to start data measurement/analysis.
- PEP pre-ejection period
- SCG sinocardiography
- BCG ballistocardiography
- the J-peak of the SCG is labelled as J x -peak for acceleration in the X-axis (also referred as head-to-foot axis), J r -peak in Y-axis (also referred as right-left axis) and J z -peak for acceleration in the Z-axis (also referred as dorso-ventral axis).
- Accelerometer signal detected on Z-axis also referred as dorso-ventral axis
- J z -peak can be used with ECG signal (e.g.
- R-J z or Q-J z time interval to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
- Accelerometer signal (detected on X-axis (also referred as head-to-foot axis) measures the body recoil movement due to blood flow.
- J x -peak signifies the time where blood pumps out from the heart and reaches the arches of Aorta blood vessel.
- R-J x time interval for blood pressure monitoring.
- R-peak of ECG or J z -peak of accelerometer can be used to trigger the start of measurement.
- the blood pressure monitoring can also be performed solely using SCG or accelerometers (e.g. J z -J x time interval).
- J z -peak signifies the time where heart contracts while J x -peak signifies the time where the blood rushes through the arches of the Aorta blood vessel. This time interval is inversely correlated to the blood pressure.
- J z -peak can also be used as the trigger to start data measurement/analysis.
- J x -peak can be used in the calculation of time intervals for monitoring blood pressure (e.g. R-J x time interval, J z -J x time interval, or J x with photoplethysmogram (PPG) signal time interval).
- PPG photoplethysmogram
- PPG photoplethysmography
- FIG. 1 illustrates an exemplary embodiment of a blood pressure monitoring system 100 .
- the system 100 can be either removably worn by a target, i.e. a patient, applied to, or placed at a sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal.
- the system 100 can be implanted into the target.
- the system 100 can be integrated into a client device either worn by the target, applied to, or positioned placed at the sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal.
- the client device may be a patch, a neckless, a chest strap, a pendant, or any suitable device.
- the system 100 may be a pacemaker, or any suitable implantable device.
- the system 100 includes a sensing assembly 102 , a processor 104 , a memory 106 , a communication interface 108 , and any suitable computer implemented modules communicatively coupled to each other via a bus.
- a housing may be provided to encapsulate at least one or more of the sensing assembly 102 , the processor 104 , the memory 106 , and the communication interface 108 .
- the housing may be formed from a thin film material that allows the target to stretch, bend, twist, squeeze, fold, expand, or combination thereof either worn by the target, applied to, reapplied to, removed from, or positioned placed at the sternum of the target.
- the memory 106 communicatively coupled to the processor 104 stores computer-readable instructions that, when executed by the processor 104 of the system 100 , causes the system, and more particularly the processor 104 , to perform or monitor vital signs and cardiac activity based on the detected signal transmitted by the sensing assembly 102 .
- the memory 106 may include any transitory, non-transitory, volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital or analog media.
- the vital signs include body temperature, pulse rate, blood pressure, and respiratory rate.
- the processor 104 may be of any type, including but not limited to a microprocessor, a microcontroller, a digital signal processor, or any combination thereof.
- the processor 104 may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers.
- the processor may be of any type, including but not limited to a microprocessor ( ⁇ P), a microcontroller ( ⁇ C), a digital signal processor (DSP), or any combination thereof.
- the processor may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers.
- the sensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram signal (SCG) and ballistocardiogram (BCG) signal.
- ECG electrocardiogram
- PPG photoplethysmorgram
- SCG seismocardiogram
- BCG ballistocardiogram
- the sensing assembly 102 is a single-axis sensing assembly.
- the sensing assembly 102 is a double-axis sensing assembly.
- the sensing assembly 102 is a multi-axis assembly.
- the sensing assembly 102 includes at least one sensor device.
- the sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer.
- a first sensor device located at a first axis of the target for detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for detecting a second time dependent motion waveform representative of the target's blood flow.
- Additional sensors provided at a location along any axis of the target to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.
- the system 100 may be a wired computing system or a wireless computing system.
- the system 100 is a cloud computing device which may be communicated with via the Internet, and which may be co-located or geographically distributed, wherein shared resources, software, and information are provided to computers and other devices on demand for example, as will be appreciated by those skilled in the art.
- the cloud blood pressure system 100 may be implemented as one or more servers which may be communicated with via the Internet.
- the system 100 may communicatively couple to a computing device 122 , a server 124 , or a network 126 via one or more links.
- the link may be wired, wireless, or combination thereof.
- the wireless communication link may include cellular protocol, data packet protocol, radio frequency protocol, satellite band, infrared channel, or any other protocol able to transmit data among client machines.
- the wired communication link may include any wired line link.
- the server 124 may be an application server, a certificate server, a mobile information server, an e-commerce server, a FTP server, a directory server, CMS server, a printer server, a management server, a mail server, a public/private access server, a real-time communication server, a database server, a proxy server, a streaming media server, or the like.
- the client machine 122 may be a personal computer or desktop computer, a laptop, a cellular or smart phone, a tablet, a personal digital assistant (PDA), a gaming console, an audio device, a video device, an entertainment device such as a television, a vehicle infotainment, a wearable device, a thin client system, a thick client system, or the like.
- the client machine 122 can in some embodiment be referred to as a single client machine or a single group of client machines, while the server 124 may be referred to as a single server or a single group of servers.
- a single client machine communicates with more than one server, while in another embodiment a single server communicates with more than one client machine.
- a single client machine communicates with a single server.
- the network 126 can comprise one or more sub-networks, and can be installed between any combination of the client machines 122 and the server 124 .
- the network 126 can be for example a local-area network (LAN), a metropolitan area network (MAN), a wide area network (WAN), a primary network 126 comprised of multiple sub-networks located between the client machines 122 and the server 124 .
- LAN local-area network
- MAN metropolitan area network
- WAN wide area network
- primary network 126 comprised of multiple sub-networks located between the client machines 122 and the server 124 .
- Still further embodiments include the network 126 that can be any network types such as a point to point network, a broadcast network, a telecommunication network, a data communication network, a computer network, an ATM (Asynchronous Transfer Mode) network, a SONET (Synchronous Optical Network) network, a SDH (Synchronous Digital Hierarchy) network, a wireless network, a wireline network, and the like.
- a point to point network a broadcast network
- a telecommunication network a data communication network
- a computer network such as a PSTN (Synchronous Optical Network) network, a SDH (Synchronous Digital Hierarchy) network, a wireless network, a wireline network, and the like.
- ATM Asynchronous Transfer Mode
- SONET Synchronous Optical Network
- SDH Synchronous Digital Hierarchy
- Additional embodiments may include a network of mobile telephone networks that use a protocol to communicate among mobile devices, where the protocol can be for example AMPS, TDMA, CDMA, GSM, GPRS, UMTS, LTE or any other protocol able to transmitdata arnong mobile devices.
- the protocol can be for example AMPS, TDMA, CDMA, GSM, GPRS, UMTS, LTE or any other protocol able to transmitdata arnong mobile devices.
- FIG. 2 illustrates a target 202 , such as a user or a patient, with a blood pressure monitoring system 200 according to a described embodiment of the disclosure.
- the system 200 identical to the system 100 depicted in FIG. 1 is placed on a sternum of the target and configured to continuously, semi-continuously, or synchronously detect or monitor at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, a seismocardiogram (SCG) signal, a ballistocardiogram (BCG) signal or environmental signal.
- ECG electrocardiogram
- PPG photoplethysmorgram
- SCG seismocardiogram
- BCG ballistocardiogram
- the system 200 is able to detect the signal that is less affected by motion artifacts.
- the system 100 may be placed on any location of the body proximal to the sternum of the target.
- the system 200 is configured to detect the time interval between heart contraction and blood flow. As illustrated, X-axis 204 , Y-axis 206 , and Z-axis 208 are provided.
- a first sensor device of the system 100 located at a first axis of the target for continuously detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for continuously detecting a second time dependent motion waveform representative of the target's blood flow.
- the first axis is the dorso-ventral axis and the second axis is the head-to-foot axis.
- the axis can be interchangeable between x, y, and z depending on position arrangement of the system 200 . If the system 200 is pointing at X-axis 204 , as illustrated in FIG.
- the first axis is the Z-axis 208 and the second axis is the X-axis 204 .
- the system 200 is pointing at Y-axis 206 , the first axis is the Z-axis 208 and the second axis is the Y-axis 206 .
- the sensor devices may be a single-axis sensor device or a double-axis sensor device.
- the sensor device is a multi-axis sensor device configured to map the resulting vector along the axis of interest, e.g. if the multi-axis sensor device is rotated and not completed aligned with for example the head-to-foot axis.
- the first and second sensor devices are accelerometers.
- FIG. 3 illustrates a sensing assembly 102 for the blood pressure monitoring system 100 .
- the sensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram (SCG) signal and ballistocardiogram (BCG) signal.
- ECG electrocardiogram
- PPG photoplethysmorgram
- SCG seismocardiogram
- BCG ballistocardiogram
- the sensing assembly 102 is a single-axis sensing assembly.
- the sensing assembly 102 is a double-axis sensing assembly.
- the sensing assembly 102 is a multi-axis assembly.
- the sensing assembly 102 includes at least one sensor device.
- the sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer.
- a first sensor device located at a first axis of the target generates a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target generates a second time dependent motion waveform representative of the target's blood flow.
- a third sensor device located at either the first or the second axis of the target generates a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle.
- the first and second sensor devices are accelerometers 102 a , 102 b and the third sensor device 102 c is either an electrode or a ECG sensor.
- a fourth sensor located along any axis of the target is provided and is configured to either detect attributes from the environment for providing context awareness information or remove motion artifacts (as reference sensor).
- FIG. 4 illustrates time-dependent waveforms, ECG waveform 300 , a first motion waveform 302 , and a second motion waveform 304 continuously monitored by the blood pressure system to determine the target's vital sign, i.e. blood pressure and cardiac activity (e.g. PEP and its influencing parameters).
- the ECG waveform 300 generated by the ECG sensor 102 c of the sensing assembly 102 placed on the target represents the electrical excitation of the heart, features a peak 310 .
- the first motion waveform 302 generated by the first accelerometer 102 a of the sensing assembly 102 represents the chest movement due to the heart contraction or the cardiac activity of the heart.
- the first motion waveform 302 is a SCG waveform in the Z-axis.
- the first motion waveform 302 is a BCG waveform in the Z-axis.
- the second motion waveform 304 generated by the second accelerometer 102 b of the sensing assembly 102 represents the body recoil movement due to the blood flow, features a peak 306 .
- the second motion waveform 304 is a SCG waveform in the X-axis.
- the second motion waveform 304 is a BCG waveform in the X-axis.
- the peak 310 also referred as R-peak of ECG waveform 300 may be used either in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
- the peak 312 also referred as Q-peak of ECG waveform 300 may also be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. Any points along the first motion waveform 302 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
- the peak 314 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
- the peak 316 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement.
- any points along second motion waveform 304 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity.
- the peak 306 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity.
- the time difference between the peaks 306 , 310 is pulse arrival time (PAT).
- the time difference between any points 312 located along the ECG waveform 300 and the peak 306 of the second motion waveform 304 features the PAT.
- the point 312 is located at Q.
- pre-ejection period PEP is defined between two points located along waveforms 300 , 302 .
- J z1 -peak 314 located along the waveform 302 can be used with point Q 312 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
- J z2 -peak 316 located along the waveform 302 can be used with point Q 312 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
- J z1 -peak 314 located along the waveform 302 can be used with peak R 310 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
- J z2 -peak 316 located along the waveform 302 can be used with peak R 310 along the ECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.
- the time difference between J z1 -peak 314 of the waveform 302 and the peak 306 of the waveform 304 features pulse transit time (PTT).
- the time interval between the J z -peak of the dorso-ventral axis to the J x -peak of the head-to-foot axis signifies the time it takes for the heart to start contracting till the time the blood flow reaches the arches of the aorta.
- This J z -J x time interval can be used to monitor blood pressure or relative blood pressure.
- the time interval can also be used to monitor other cardiovascular parameters such as arterial stiffness, as one example.
- blood pressure can be monitored by measuring the blood flow velocity profile of two PPG signals at two different locations at the time intervals.
- the blood flow velocity can be measured using a Doppler ultrasonic transducer. This method uses reflection of ultrasonic irradiation of frequency f 0 from the blood in any arteries, e.g. the Aorta, with additional ultrasonic frequencies appearing in the reflected wave spectrum as sidebands at spectral position f 0 +/ ⁇ f, with ⁇ f being a time-dependent function of blood velocity v(t):
- the peak reading of ⁇ f or its amplitude ⁇ f A corresponds to the peak velocity v A of the blood ejected from the heart into the aorta, and has a correlation to blood pressure.
- ⁇ f A or v A corresponds to the systolic blood pressure.
- the measurement of ⁇ f can be done by synchronous demodulation of the reflected ultrasonic signal spectrum with the center frequency f 0 into the base-band, by a combination of mixing stage and low-pass filter, or any suitable FM-demodulation technique.
- Phase-locked loop demodulators, ratio-detectors, and any suitable active components, depending on the applications, may be used.
- the sensor device may be any suitable piezoelectric or electrostatic/capacitive bending actuator or bimorph configured to convert an electrical carrier frequency signal at f 0 into an ultrasonic wave, and an incoming ultrasonic wave spectrum is converted back to an electrical signal spectrum for further analysis.
- at least one accelerometer signal can be used, depending on the application, to trigger the ultrasonic irradiation and evaluation loop, for cross-correlating data, and for providing context-awareness information. More than one accelerometer of the system 200 can also be used to detect if the user is moving or the kind of activity the user is doing, to add additional information to the user. The additional accelerometer can also be utilized to reduce/filter motion artifacts from the J x or J z data.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physiology (AREA)
- Vascular Medicine (AREA)
- Computer Networks & Wireless Communication (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Hematology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
Description
- This application claims the benefit of U.S. Provisional Application No. 62/319,920, filed Apr. 8, 2016, which is incorporated herein by reference.
- This disclosure is related to health monitoring devices, and more particularly, to a blood pressure and cardiac monitoring system and method for monitoring vital signs.
- A summary of certain embodiments disclosed herein is set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of these certain embodiments and that these aspects are not intended to limit the scope of this disclosure. Indeed, this disclosure may encompass a variety of aspects that may not be set forth below.
- Embodiments of the disclosure related to a blood pressure and cardiac monitoring system are described. For example, the system comprises a sensing assembly and a processor communicatively coupled to the sensing assembly. The sensing assembly comprises a first accelerometer located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second accelerometer located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow. The processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
- In another embodiment, a third sensor located either along the first or the second axis of the target generating a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle is provided.
- In yet another embodiment, a fourth sensor located along any axis of the target is provided.
- In one or more embodiments, the fourth sensor is configured to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information.
- Embodiments of another disclosure relates to a sensing assembly for monitoring vital signs includes a first sensor located at a first axis of a target generating a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor located at a second axis of the target generating a second time dependent motion waveform representative of the target's blood flow. A processor configured to receive the first time dependent motion waveform and the second time dependent motion waveform, and to determine a first time difference between a vital sign present in the first time dependent motion waveform and the second time dependent motion waveform.
- In one or more embodiments, a housing is provided to encapsulate the processor and the sensing assembly.
- In one or more embodiments, the processor is remotely located outside the sensing assembly and is communicatively coupled to the sensing assembly via a wireless network.
- These and other features, aspects, and advantages of this disclosure will become better understood when the following detailed description of certain exemplary embodiments is read with reference to the accompanying drawings in which like characters represent like arts throughout the drawings, wherein:
-
FIG. 1 illustrates a block diagram of a blood pressure monitoring system according to an exemplary embodiment of a disclosure; -
FIG. 2 illustrates a target with a blood pressure monitoring system ofFIG. 1 placed on a sternum of the target according to a described embodiment of the disclosure; -
FIG. 3 illustrates a sensing assembly for the blood pressure monitoring system ofFIG. 1 according to a described embodiment of the disclosure; and -
FIG. 4 illustrates a graph of time-dependent waveforms according to an exemplary embodiment of the disclosure. - One or more specific embodiments will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
- The following description is presented to enable any person skilled in the art to make and use the described embodiments, and is provided in the context of a particular application and its requirements. Various modifications to the described embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the described embodiments. Thus, the described embodiments are not limited to the embodiments shown, but are to be accorded the widest scope consistent with the principles and features disclosed herein.
- As used herein, the term “electrocardiography (ECG)” refers to the changes of the electrical potential due to the depolarization of heart muscle. R-peak of the ECG signal can be used in the calculation of time intervals for monitoring blood pressure (e.g. RJ-time interval), R-peak or Q-peak of ECG signal for monitoring cardiac activity (e.g. pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc.) or as the trigger to start data measurement/analysis. The term “seismocardiography (SCG)” refers to the acceleration of the sternum caused by the cardiac activity of the heart while the term “ballistocardiography (BCG)” refers to the changes in the center of mass of the body due to blood flow or heart activity. The J-peak of the RJ-time interval comes from the peak obtained from either SCG or BCG. In an example case where a tri-axis accelerometer is used for SCG measurement, the J-peak of the SCG is labelled as Jx-peak for acceleration in the X-axis (also referred as head-to-foot axis), Jr-peak in Y-axis (also referred as right-left axis) and Jz-peak for acceleration in the Z-axis (also referred as dorso-ventral axis). Accelerometer signal detected on Z-axis (also referred as dorso-ventral axis) measures the chest movement due to heart contraction. Jz-peak can be used with ECG signal (e.g. R-Jz or Q-Jz time interval) to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. Accelerometer signal (detected on X-axis (also referred as head-to-foot axis) measures the body recoil movement due to blood flow. Jx-peak signifies the time where blood pumps out from the heart and reaches the arches of Aorta blood vessel. One example will be R-Jx time interval for blood pressure monitoring. In the measurement of the time intervals, R-peak of ECG or Jz-peak of accelerometer can be used to trigger the start of measurement.
- The blood pressure monitoring can also be performed solely using SCG or accelerometers (e.g. Jz-Jx time interval). Jz-peak signifies the time where heart contracts while Jx-peak signifies the time where the blood rushes through the arches of the Aorta blood vessel. This time interval is inversely correlated to the blood pressure. Jz-peak can also be used as the trigger to start data measurement/analysis. Jx-peak can be used in the calculation of time intervals for monitoring blood pressure (e.g. R-Jx time interval, Jz-Jx time interval, or Jx with photoplethysmogram (PPG) signal time interval). The term “photoplethysmography (PPG)” refers to the changes in light adsorption in blood. Depending on the position where the PPG data is taken, the time interval between R-peak with PPG, Jz-peak (from SCG) with PPG, Jx-peak (from SCG) with PPG, PPG in one location with PPG in another location, can be used to monitor blood pressure or blood flow velocity.
-
FIG. 1 illustrates an exemplary embodiment of a bloodpressure monitoring system 100. Thesystem 100 can be either removably worn by a target, i.e. a patient, applied to, or placed at a sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal. In some embodiments, thesystem 100 can be implanted into the target. In another embodiment, thesystem 100 can be integrated into a client device either worn by the target, applied to, or positioned placed at the sternum of the target and configured to either continuously, semi-continuously, or synchronously detected at least one signal. As some examples, the client device may be a patch, a neckless, a chest strap, a pendant, or any suitable device. If thesystem 100 is implantable into the target, thesystem 100 may be a pacemaker, or any suitable implantable device. Thesystem 100 includes asensing assembly 102, aprocessor 104, amemory 106, acommunication interface 108, and any suitable computer implemented modules communicatively coupled to each other via a bus. A housing may be provided to encapsulate at least one or more of thesensing assembly 102, theprocessor 104, thememory 106, and thecommunication interface 108. In one embodiment, the housing may be formed from a thin film material that allows the target to stretch, bend, twist, squeeze, fold, expand, or combination thereof either worn by the target, applied to, reapplied to, removed from, or positioned placed at the sternum of the target. Thememory 106 communicatively coupled to theprocessor 104 stores computer-readable instructions that, when executed by theprocessor 104 of thesystem 100, causes the system, and more particularly theprocessor 104, to perform or monitor vital signs and cardiac activity based on the detected signal transmitted by thesensing assembly 102. Thememory 106 may include any transitory, non-transitory, volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital or analog media. The vital signs include body temperature, pulse rate, blood pressure, and respiratory rate. - The
processor 104 may be of any type, including but not limited to a microprocessor, a microcontroller, a digital signal processor, or any combination thereof. Theprocessor 104 may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers. Depending on the desired configuration, the processor may be of any type, including but not limited to a microprocessor (μP), a microcontroller (μC), a digital signal processor (DSP), or any combination thereof. The processor may include one or more levels of caching, such as a level cache memory, one or more processor cores, and registers. The example processor cores may (each) include an arithmetic logic unit (ALU), a floating point unit (FPU), a digital signal processing core (DSP Core), or any combination thereof. An example memory controller may also be used with the processor, or in some implementations the memory controller may be an internal part of the processor. Thecommunication interface 108 allows software and data to be transferred between a computer system external to thesystem 100 and the system in the form of signals which may be, for example, electronic, electromagnetic, optical, or other signals capable of being received by the communication interface. The communication interface may be for example a modem, a network interface, a communication port, a PCM-CIA slot and card, or the like. Thesensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram signal (SCG) and ballistocardiogram (BCG) signal. In one embodiment, thesensing assembly 102 is a single-axis sensing assembly. In another embodiment, thesensing assembly 102 is a double-axis sensing assembly. In yet another embodiment, thesensing assembly 102 is a multi-axis assembly. As an example, thesensing assembly 102 includes at least one sensor device. The sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer. As an example, a first sensor device located at a first axis of the target for detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for detecting a second time dependent motion waveform representative of the target's blood flow. Additional sensors provided at a location along any axis of the target to either remove motion artifacts (as a reference sensor) or detect attributes from the environment for providing context awareness information. - The
system 100 may be a wired computing system or a wireless computing system. In one embodiment, thesystem 100 is a cloud computing device which may be communicated with via the Internet, and which may be co-located or geographically distributed, wherein shared resources, software, and information are provided to computers and other devices on demand for example, as will be appreciated by those skilled in the art. In another embodiment, the cloudblood pressure system 100 may be implemented as one or more servers which may be communicated with via the Internet. Thesystem 100 may communicatively couple to acomputing device 122, aserver 124, or anetwork 126 via one or more links. The link may be wired, wireless, or combination thereof. The wireless communication link may include cellular protocol, data packet protocol, radio frequency protocol, satellite band, infrared channel, or any other protocol able to transmit data among client machines. The wired communication link may include any wired line link. - Depending on the application, one or more servers may be communicatively coupled to the
computing device 122 to and thesystem 100. Theserver 124 may be an application server, a certificate server, a mobile information server, an e-commerce server, a FTP server, a directory server, CMS server, a printer server, a management server, a mail server, a public/private access server, a real-time communication server, a database server, a proxy server, a streaming media server, or the like. Theclient machine 122 may be a personal computer or desktop computer, a laptop, a cellular or smart phone, a tablet, a personal digital assistant (PDA), a gaming console, an audio device, a video device, an entertainment device such as a television, a vehicle infotainment, a wearable device, a thin client system, a thick client system, or the like. Theclient machine 122 can in some embodiment be referred to as a single client machine or a single group of client machines, while theserver 124 may be referred to as a single server or a single group of servers. In one embodiment a single client machine communicates with more than one server, while in another embodiment a single server communicates with more than one client machine. In yet another embodiment, a single client machine communicates with a single server. Thenetwork 126 can comprise one or more sub-networks, and can be installed between any combination of theclient machines 122 and theserver 124. In some embodiments, thenetwork 126 can be for example a local-area network (LAN), a metropolitan area network (MAN), a wide area network (WAN), aprimary network 126 comprised of multiple sub-networks located between theclient machines 122 and theserver 124. Still further embodiments include thenetwork 126 that can be any network types such as a point to point network, a broadcast network, a telecommunication network, a data communication network, a computer network, an ATM (Asynchronous Transfer Mode) network, a SONET (Synchronous Optical Network) network, a SDH (Synchronous Digital Hierarchy) network, a wireless network, a wireline network, and the like. Depending on the application, other networks may be used so that data exchanged between the client machine and the server can be transmitted over the network. Network topology of thenetwork 124 can differ within different embodiments which may include a. bus network topology, a star network topology, a ring network topology, a repeater-based network topology, or a tiered-star network topology. Additional embodiments may include a network of mobile telephone networks that use a protocol to communicate among mobile devices, where the protocol can be for example AMPS, TDMA, CDMA, GSM, GPRS, UMTS, LTE or any other protocol able to transmitdata arnong mobile devices. -
FIG. 2 illustrates atarget 202, such as a user or a patient, with a bloodpressure monitoring system 200 according to a described embodiment of the disclosure. Thesystem 200 identical to thesystem 100 depicted inFIG. 1 is placed on a sternum of the target and configured to continuously, semi-continuously, or synchronously detect or monitor at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, a seismocardiogram (SCG) signal, a ballistocardiogram (BCG) signal or environmental signal. In some embodiments, thesystem 200 is placed on the sternum of the target for sensing movement of the chest wall. Since bones can transfer the body movement due to cardiac activities with less damping effects than muscles, thesystem 200 is able to detect the signal that is less affected by motion artifacts. In another embodiment, thesystem 100 may be placed on any location of the body proximal to the sternum of the target. In yet another embodiment, thesystem 200 is configured to detect the time interval between heart contraction and blood flow. As illustrated,X-axis 204, Y-axis 206, and Z-axis 208 are provided. A first sensor device of thesystem 100 located at a first axis of the target for continuously detecting a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target for continuously detecting a second time dependent motion waveform representative of the target's blood flow. The first axis is the dorso-ventral axis and the second axis is the head-to-foot axis. The axis can be interchangeable between x, y, and z depending on position arrangement of thesystem 200. If thesystem 200 is pointing atX-axis 204, as illustrated inFIG. 2 the first axis is the Z-axis 208 and the second axis is theX-axis 204. In another embodiment, thesystem 200 is pointing at Y-axis 206, the first axis is the Z-axis 208 and the second axis is the Y-axis 206. The sensor devices may be a single-axis sensor device or a double-axis sensor device. In another embodiment, the sensor device is a multi-axis sensor device configured to map the resulting vector along the axis of interest, e.g. if the multi-axis sensor device is rotated and not completed aligned with for example the head-to-foot axis. As illustrated, the first and second sensor devices are accelerometers. -
FIG. 3 illustrates asensing assembly 102 for the bloodpressure monitoring system 100. Thesensing assembly 102 is configured to detect at least one or more of electrocardiogram (ECG) signal, a first motion signal, a second motion signal, a photoplethysmorgram (PPG) signal, seismocardiogram (SCG) signal and ballistocardiogram (BCG) signal. In one embodiment, thesensing assembly 102 is a single-axis sensing assembly. In another embodiment, thesensing assembly 102 is a double-axis sensing assembly. In yet another embodiment, thesensing assembly 102 is a multi-axis assembly. As an example, thesensing assembly 102 includes at least one sensor device. The sensor device may be an accelerometer, a motion sensor, an optical sensor, a transducer, a Doppler ultrasonic transducer, an acoustic sensor, an electrode, an ECG sensor, a target orientation sensor, a sonar sensor, a thermal sensor, an environmental sensor, and any suitable sensor or transducer. As an example, a first sensor device located at a first axis of the target generates a first time-dependent motion waveform representative of one or more contractile properties of the target's heart and a second sensor device located at a second axis of the target generates a second time dependent motion waveform representative of the target's blood flow. As another example, a third sensor device located at either the first or the second axis of the target generates a third time dependent waveform representative of the electrical potential due to the depolarization of heart muscle. In one embodiment, the first and second sensor devices areaccelerometers third sensor device 102 c is either an electrode or a ECG sensor. In another embodiment, a fourth sensor located along any axis of the target is provided and is configured to either detect attributes from the environment for providing context awareness information or remove motion artifacts (as reference sensor). -
FIG. 4 illustrates time-dependent waveforms,ECG waveform 300, afirst motion waveform 302, and asecond motion waveform 304 continuously monitored by the blood pressure system to determine the target's vital sign, i.e. blood pressure and cardiac activity (e.g. PEP and its influencing parameters). TheECG waveform 300, generated by theECG sensor 102 c of thesensing assembly 102 placed on the target represents the electrical excitation of the heart, features apeak 310. Thefirst motion waveform 302 generated by thefirst accelerometer 102 a of thesensing assembly 102 represents the chest movement due to the heart contraction or the cardiac activity of the heart. In one embodiment, thefirst motion waveform 302 is a SCG waveform in the Z-axis. In another embodiment, thefirst motion waveform 302 is a BCG waveform in the Z-axis. Thesecond motion waveform 304, generated by thesecond accelerometer 102 b of thesensing assembly 102 represents the body recoil movement due to the blood flow, features apeak 306. In one embodiment, thesecond motion waveform 304 is a SCG waveform in the X-axis. In another embodiment, thesecond motion waveform 304 is a BCG waveform in the X-axis. Thepeak 310 also referred as R-peak ofECG waveform 300 may be used either in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. Thepeak 312 also referred as Q-peak ofECG waveform 300 may also be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. Any points along thefirst motion waveform 302 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. As an example, thepeak 314 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. As another example, thepeak 316 may be used in calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity or to trigger a start of blood pressure measurement. Any points alongsecond motion waveform 304 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity. As one example, thepeak 306 may be used in the calculation of time intervals for monitoring blood pressure, vital signs and cardiac activity. In one embodiment, the time difference between thepeaks points 312 located along theECG waveform 300 and thepeak 306 of thesecond motion waveform 304 features the PAT. As an example, thepoint 312 is located at Q. As described previously, pre-ejection period (PEP) is defined between two points located alongwaveforms peak 314 located along thewaveform 302 can be used withpoint Q 312 along theECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. In yet another embodiment, Jz2-peak 316 located along thewaveform 302 can be used withpoint Q 312 along theECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. In yet another embodiment, Jz1-peak 314 located along thewaveform 302 can be used withpeak R 310 along theECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. In further yet another embodiment, Jz2-peak 316 located along thewaveform 302 can be used withpeak R 310 along theECG waveform 300 to investigate important cardiac activity such as the pre-ejection period (PEP) and its influencing parameters such as hormones, preload, afterload, etc. As one embodiment, the time difference between Jz1-peak 314 of thewaveform 302 and thepeak 306 of thewaveform 304 features pulse transit time (PTT). - The time interval between the Jz-peak of the dorso-ventral axis to the Jx-peak of the head-to-foot axis signifies the time it takes for the heart to start contracting till the time the blood flow reaches the arches of the aorta. This Jz-Jx time interval can be used to monitor blood pressure or relative blood pressure. The time interval can also be used to monitor other cardiovascular parameters such as arterial stiffness, as one example.
- As described above, blood pressure can be monitored by measuring the blood flow velocity profile of two PPG signals at two different locations at the time intervals. Alternatively, the blood flow velocity can be measured using a Doppler ultrasonic transducer. This method uses reflection of ultrasonic irradiation of frequency f0 from the blood in any arteries, e.g. the Aorta, with additional ultrasonic frequencies appearing in the reflected wave spectrum as sidebands at spectral position f0+/−Δf, with Δf being a time-dependent function of blood velocity v(t):
-
Δf(t)=Δf(v)=Δf(v(t)) - The peak reading of Δf or its amplitude ΔfA corresponds to the peak velocity vA of the blood ejected from the heart into the aorta, and has a correlation to blood pressure. ΔfA or vA corresponds to the systolic blood pressure.
- The minimum reading of Δf in between 2 maxima ΔfA, namely Δfmin has a correlation to the minimum blood velocity vmin and to blood pressure as well. Δfmin or vmin corresponds to the diastolic blood pressure.
- The measurement of Δf can be done by synchronous demodulation of the reflected ultrasonic signal spectrum with the center frequency f0 into the base-band, by a combination of mixing stage and low-pass filter, or any suitable FM-demodulation technique. Phase-locked loop demodulators, ratio-detectors, and any suitable active components, depending on the applications, may be used.
- In yet another embodiment, the sensor device may be any suitable piezoelectric or electrostatic/capacitive bending actuator or bimorph configured to convert an electrical carrier frequency signal at f0 into an ultrasonic wave, and an incoming ultrasonic wave spectrum is converted back to an electrical signal spectrum for further analysis. In addition, at least one accelerometer signal can be used, depending on the application, to trigger the ultrasonic irradiation and evaluation loop, for cross-correlating data, and for providing context-awareness information. More than one accelerometer of the
system 200 can also be used to detect if the user is moving or the kind of activity the user is doing, to add additional information to the user. The additional accelerometer can also be utilized to reduce/filter motion artifacts from the Jx or Jz data. - The embodiments described above have been shown by way of example, and it should be understood that these embodiments may be susceptible to various modifications and alternative forms. It should be further understood that the claims are not intended to be limited to the particular forms disclosed, but rather to cover all modifications, equivalents, and alternatives falling with the sprit and scope of this disclosure.
- While the patent has been described with reference to various embodiments, it will be understood that these embodiments are illustrative and that the scope of the disclosure is not limited to them. Many variations, modifications, additions, and improvements are possible. More generally, embodiments in accordance with the patent have been described in the context or particular embodiments. Functionality may be separated or combined in blocks differently in various embodiments of the disclosure or described with different terminology. These and other variations, modifications, additions, and improvements may fall within the scope of the disclosure as defined in the claims that follow.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/564,585 US20180192888A1 (en) | 2016-04-08 | 2017-04-10 | Blood Pressure and Cardiac Monitoring System and Method Thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662319920P | 2016-04-08 | 2016-04-08 | |
PCT/EP2017/058487 WO2017174814A1 (en) | 2016-04-08 | 2017-04-10 | Blood pressure and cardiac monitoring system and method thereof |
US15/564,585 US20180192888A1 (en) | 2016-04-08 | 2017-04-10 | Blood Pressure and Cardiac Monitoring System and Method Thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2017/058487 A-371-Of-International WO2017174814A1 (en) | 2016-04-08 | 2017-04-10 | Blood pressure and cardiac monitoring system and method thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/834,686 Continuation-In-Part US11051705B2 (en) | 2016-04-08 | 2017-12-07 | Blood pressure and cardiac monitoring system and method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180192888A1 true US20180192888A1 (en) | 2018-07-12 |
Family
ID=58536977
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/564,585 Abandoned US20180192888A1 (en) | 2016-04-08 | 2017-04-10 | Blood Pressure and Cardiac Monitoring System and Method Thereof |
US15/834,686 Active 2039-04-23 US11051705B2 (en) | 2016-04-08 | 2017-12-07 | Blood pressure and cardiac monitoring system and method thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/834,686 Active 2039-04-23 US11051705B2 (en) | 2016-04-08 | 2017-12-07 | Blood pressure and cardiac monitoring system and method thereof |
Country Status (3)
Country | Link |
---|---|
US (2) | US20180192888A1 (en) |
EP (1) | EP3463066B1 (en) |
WO (1) | WO2017174814A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200100705A1 (en) * | 2017-06-23 | 2020-04-02 | Koninklijke Philips N.V. | Device, system and method for detection of pulse and/or pulse-related information of a patient |
WO2020205987A1 (en) * | 2019-04-01 | 2020-10-08 | VivaLnk, Inc. | Systems, devices, and methods for non-invasive cardiac monitoring |
US11504047B2 (en) | 2017-12-28 | 2022-11-22 | Heart Force Medical Inc. | Sensor apparatuses, methods of operating same, and systems including same, and methods and systems for sensing and analyzing electromechanical characteristics of a heart |
WO2023158985A1 (en) * | 2022-02-15 | 2023-08-24 | Cardiosounds Llc | Vibro-acoustic modeling of cardiac activity |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10849508B2 (en) * | 2016-06-03 | 2020-12-01 | Fourth Frontier Technologies Pvt. Ltd. | System and method for continuous monitoring of blood pressure |
US11660052B2 (en) | 2017-11-09 | 2023-05-30 | Robert Bosch Gmbh | Vital signs monitoring system and method |
WO2019162490A1 (en) * | 2018-02-26 | 2019-08-29 | Robert Bosch Gmbh | Wearable health device system with normalized seismocardiography signals |
CN108852322A (en) * | 2018-02-26 | 2018-11-23 | 南京邮电大学 | It is a kind of based on PWV without constraint blood pressure measuring system |
CN108324260A (en) * | 2018-02-28 | 2018-07-27 | 湖南可孚医疗科技发展有限公司 | A kind of blood pressure monitoring system based on big data |
US11185237B2 (en) * | 2018-03-06 | 2021-11-30 | Robert Bosch Gmbh | Calibration methods for blood pressure devices |
FI20186044A1 (en) * | 2018-12-04 | 2020-06-05 | Myllylae Teemu | Biosignal measurement apparatus and method |
US12023165B2 (en) | 2020-10-23 | 2024-07-02 | Northwestern University | Screening cardiac conditions using cardiac vibrational energy spectral heat maps |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8475370B2 (en) * | 2009-05-20 | 2013-07-02 | Sotera Wireless, Inc. | Method for measuring patient motion, activity level, and posture along with PTT-based blood pressure |
US20110066041A1 (en) * | 2009-09-15 | 2011-03-17 | Texas Instruments Incorporated | Motion/activity, heart-rate and respiration from a single chest-worn sensor, circuits, devices, processes and systems |
WO2014036436A1 (en) * | 2012-08-30 | 2014-03-06 | Alivecor, Inc. | Cardiac performance monitoring system for use with mobile communications devices |
US10856742B2 (en) * | 2014-02-06 | 2020-12-08 | Sotera Wireless, Inc. | Body-worn system for continuous, noninvasive measurement of vital signs |
US20160081563A1 (en) * | 2014-09-23 | 2016-03-24 | PhysioWave, Inc. | Systems and methods to estimate or measure hemodynamic output and/or related cardiac output |
-
2017
- 2017-04-10 US US15/564,585 patent/US20180192888A1/en not_active Abandoned
- 2017-04-10 EP EP17716861.4A patent/EP3463066B1/en active Active
- 2017-04-10 WO PCT/EP2017/058487 patent/WO2017174814A1/en unknown
- 2017-12-07 US US15/834,686 patent/US11051705B2/en active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200100705A1 (en) * | 2017-06-23 | 2020-04-02 | Koninklijke Philips N.V. | Device, system and method for detection of pulse and/or pulse-related information of a patient |
US11957454B2 (en) * | 2017-06-23 | 2024-04-16 | Koninklijke Philips N.V. | Device, system and method for detection of pulse and/or pulse-related information of a patient |
US11504047B2 (en) | 2017-12-28 | 2022-11-22 | Heart Force Medical Inc. | Sensor apparatuses, methods of operating same, and systems including same, and methods and systems for sensing and analyzing electromechanical characteristics of a heart |
WO2020205987A1 (en) * | 2019-04-01 | 2020-10-08 | VivaLnk, Inc. | Systems, devices, and methods for non-invasive cardiac monitoring |
WO2023158985A1 (en) * | 2022-02-15 | 2023-08-24 | Cardiosounds Llc | Vibro-acoustic modeling of cardiac activity |
Also Published As
Publication number | Publication date |
---|---|
EP3463066B1 (en) | 2023-08-16 |
EP3463066A1 (en) | 2019-04-10 |
WO2017174814A1 (en) | 2017-10-12 |
US11051705B2 (en) | 2021-07-06 |
US20180092533A1 (en) | 2018-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11051705B2 (en) | Blood pressure and cardiac monitoring system and method thereof | |
US11660052B2 (en) | Vital signs monitoring system and method | |
US11691001B2 (en) | Methods for transcutaneous facial nerve stimulation and applications thereof | |
US11826119B2 (en) | Internet-linked ultrasonic network for medical devices | |
Chandrasekaran et al. | Cuffless differential blood pressure estimation using smart phones | |
US9566033B2 (en) | Garment system with electronic components and associated methods | |
JP6150952B2 (en) | Method and apparatus for determining the direction of an accelerometer | |
US20160206277A1 (en) | Systems and methods for monitoring heart rate using acoustic sensing | |
JP7116810B2 (en) | Wearable Computers with Connectivity to Health Devices for Improved Behavioral Monitoring Using Calorie Expenditure Models | |
WO2014078210A3 (en) | Piezoelectric heart rate sensing for wearable devices or mobile devices | |
KR102534876B1 (en) | Method and apparatus for determining the breathing status of a person using a depth camera | |
Horng et al. | The smart fall detection mechanism for healthcare under free-living conditions | |
Erfianto et al. | IMU‐Based respiratory signal processing using cascade complementary filter method | |
JP2017059089A (en) | Step counting device, step counting method, and program | |
JP6642055B2 (en) | Sensor information processing device, sensor unit, and sensor information processing program | |
CN114947771A (en) | Human body characteristic data acquisition method and device | |
Wu et al. | Accurate stride length estimation via fused radio and inertial sensing | |
CN117043634A (en) | Angular and linear movement detection and compensation for user equipment | |
CN207574548U (en) | A kind of personal jacket and Wearable | |
Baiamonte et al. | Synchronized Vibration Data Acquisition for Seismocardiography | |
He et al. | TreMo: Continuous Vital Sign Monitoring Based on Subtle Intrinsic Tremors with COTS Mobile Devices | |
Majumder | Wearable Systems For Health Monitoring Towards Active Aging | |
CN118436324A (en) | Pulse arrival time difference acquisition method, central blood pressure acquisition method and device | |
CN116720096A (en) | Movement assessment methods, electronic devices and systems | |
KR20160011958A (en) | A wearable sensing device for detecting biological signal and information on exercise |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: ROBERT BOSCH GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YEE, SEOW YUEN;PETERS, CHRISTIAN;ROCZNIK, THOMAS;AND OTHERS;SIGNING DATES FROM 20180328 TO 20180504;REEL/FRAME:046856/0510 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |